Current Report Filing (8-k)
November 15 2021 - 7:35AM
Edgar (US Regulatory)
0001739174
false
0001739174
2021-11-15
2021-11-15
0001739174
PHGE:UnitsEachConsistingOfOneShareOfCommonStock0.0001ParValueAndOneWarrantEntitlingHolderToReceiveOneHalfShareOfCommonStockMember
2021-11-15
2021-11-15
0001739174
PHGE:SharesOfCommonStock0.0001ParValueMember
2021-11-15
2021-11-15
0001739174
PHGE:WarrantsEachExercisableForOnehalfOfShareOfCommonStock0.0001ParValueAtExercisePriceOf11.50PerShareMember
2021-11-15
2021-11-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 15, 2021
|
BiomX
Inc.
|
|
|
(Exact Name of Registrant
as Specified in its Charter)
|
|
Delaware
|
|
001-38762
|
|
82-3364020
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
22 Einstein St., Floor 5
Ness Ziona, Israel
|
|
7414003
|
(Address of Principal Executive
Offices)
|
|
(Zip Code)
|
Registrant’s
telephone number, including area code: +972 723942377
|
n/a
|
|
|
(Former name or former address,
if changed since last report)
|
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on
which registered
|
Units, each consisting of
one share of Common Stock, $0.0001 par value, and one Warrant entitling the holder to receive one half share of Common Stock
|
|
PHGE.U
|
|
NYSE American
|
Shares of Common Stock,
$0.0001 par value
|
|
PHGE
|
|
NYSE American
|
Warrants, each exercisable
for one-half of a share of common stock, $0.0001 par value, at an exercise price of $11.50 per share
|
|
PHGE.WS
|
|
NYSE American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.02 Results of Operations and Financial Condition.
On
November 15, 2021, BiomX Inc., or the Company, issued a press release announcing its financial results for the third quarter ended
September 30, 2021. A copy of the press release issued in connection with the announcement is furnished pursuant to Item 2.02 as Exhibit
99.1 hereto.
Item
7.01 Regulation FD Disclosure.
The
Company from time to time presents and/or distributes to the investment community at various industry and other conferences slide presentations
to provide updates and summaries of its business. On November 15, 2021, the Company posted an updated corporate slide presentation in
the “Investors” portion of its website at www.biomx.com. A copy of the slide presentation is furnished pursuant to Item 7.01
as Exhibit 99.2 hereto. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit
99.2.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
BIOMX INC.
|
|
|
|
November 15, 2021
|
By:
|
/s/
Jonathan Solomon
|
|
|
Name:
|
Jonathan Solomon
|
|
|
Title:
|
Chief Executive Officer
|
2
BiomX (AMEX:PHGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
BiomX (AMEX:PHGE)
Historical Stock Chart
From Sep 2023 to Sep 2024